Registro:

Referencias:

• Aronica, S.M., Katzenellenbogen, B.S., Progesterone receptor regulation in uterine cells: Stimulation by estrogen, cyclic adenosine 3′,5′-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors (1991) Endocrinology., 128, pp. 2045-2052
• Bagowski, C.P., Myers, J.W., Ferrell J.E., Jr., The classical progesterone receptor associates with p42MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes (2001) J. Biol. Chem., 276, pp. 37708-37714
• Bai, W., Rowan, B.G., Allgood, V.E., O'Malley, B.W., Weigel, N.L., Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation (1997) J. Biol. Chem., 272, pp. 10457-10463
• Balañá, M.E., Labriola, L., Salatino, M., Movsichoff, F., Peters, G., Charreau, E.H., Elizalde, P.V., Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells (2001) Oncogene, 20, pp. 34-47
• Balañá, M.E., Lupu, R., Labriola, L., Charreau, E.H., Elizalde, P.V., Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas (1999) Oncogene, 18, pp. 6370-6379
• Baserga, R., The insulin-like growth factor I receptor: A key to tumor growth (1995) Cancer Res., 55, pp. 249-252
• Beck, C.A., Weigel, N.L., Edwards, D.P., Effect of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors (1992) Mol. Endocrinol., 6, pp. 607-620
• Beerli, R.R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y., Hynes, N.E., Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2 (1995) Mol. Cell. Biol., 15, pp. 6496-6505
• Boonjarantanakornkit, V., Porter Scott, M., Ribon, V., Sherman, L., Anderson, S.M., Maller, J.L., Miller, W.T., Edwards, D.P., Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-SRC family tyrosine kinases (2001) Mol. Cell, 8, pp. 269-280
• Braunsberg, H., Coldham, N.G., Learke, R.E., Cowan, S.K., Wong, W., Actions of progestogen on human breast cancer cells: Mechanisms of growth stimulation and inhibition (1987) Eur. J. Cancer Clin. Oncol., 23, pp. 563-571
• Bunone, G., Briand, P.A., Miksicek, R.J., Picard, D., Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation (1996) EMBO J., 15, pp. 2174-2183
• Cho, H., Aronica, S.M., Katzenellenbogen, B.S., Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: A comparison of the effects of cyclic adenosine 3′,5′-monophosphate, estradiol, insulin growth factor I, and serum factors (1994) Endocrinology, 134, pp. 658-664
• Clarke, C.L., Sutherland, R.L., Progestin regulation of cellular proliferation (1990) Endocrinol. Rev., 11, pp. 266-302
• Clemm, D.L., Sherman, L., Boonyaratanakornkit, V., Schrader, W.T., Weigel, N.L., Edwards, D.P., Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody (2000) Mol. Endocrinol., 14, pp. 52-65
• Cohen, G.B., Ren, R., Baltimore, D., Modular binding domains in signal transduction proteins (1995) Cell, 80, pp. 237-248
• Colomer, R., Lupu, R., Bacus, S.S., Gelmann, E.P., ErbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification (1994) Br. J. Cancer, 70, pp. 819-825
• Coso, O.A., Montaner, S., Fromm, C., Lacal, J.C., Prywes, R., Teramoto, H., Gutkind, J.S., Signaling from G protein-coupled receptors to the c-Jun promoter involves the MEF2 transcription factor (1997) J. Biol. Chem., 272, pp. 20691-20697
• Curtis, S.W., Washburn, T., Sewall, C., Di Augustine, R., Lindzey, J., Couse, J.F., Korach, K.S., Physiological coupling of growth factor and steroid receptor signaling pathways: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 12626-12630
• Denner, L.A., Weigel, N.L., Maxwell, B.L., Schrader, W.T., O'Malley, B.W., Regulation of progesterone receptor-mediated transcription by phosphorylation (1990) Science, 250, pp. 1740-1743
• Denner, L.A., Weigel, N.L., Schrader, W.T., O'Malley, B.W., Hormone-dependent regulation of chicken progesterone receptor deoxyribonucleic acid binding and phosphorylation (1989) Endocrinology, 125, pp. 3051-3058
• Dran, G., Luthy, I.A., Molinolo, A.A., Montecchia, F., Charreau, E.H., Pasqualini, C.D., Lanari, C., Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma (1995) Breast Cancer Res. Treatment., 35, pp. 173-186
• Edwards, D.P., Weigel, N.L., Nordeen, S.K., Beck, C.A., Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists (1993) Breast Cancer Res. Treatment., 27, pp. 41-56
• Egan, S.E., Weinberg, R.A., The pathway to signal achievement (1993) Nature, 365, pp. 781-783
• El-Ashry, D., Oñate, S.A., Nordeen, S.K., Edwards, D.P., Human progesterone receptor complexed with the antagonist RU486 binds to hormone response elements in a structurally altered form (1989) Mol. Endocrinol., 3, pp. 1545-1558
• Fiddes, R.J., Janes, P.W., Silversten, S.P., Sutherland, R.L., Musgrove, E.A., Daly, R.J., Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells (1998) Oncogene, 16, pp. 2803-2813
• Gass, E.K., Leonhardt, S.A., Nordeen, S.K., Edwards, D.P., The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo but have distinct effects on receptor conformation (1998) Endocrinology, 139, pp. 1905-1919
• Graus-Porta, D., Beerli, R.R., Hynes, N.E., Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling (1995) Mol. Cell. Biol., 15, pp. 1182-1191
• Graus-Porta, D., Beerli, R.R., Daly, J.M., Hynes, N.E., ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling (1997) EMBO J., 16, pp. 1647-1655
• Groshong, S.D., Owen, G.L., Grimison, B., Schauer, I.E., Todd, M.C., Langan, T.A., Sclafani, R.A., Horwitz, K.B., Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitor, p21 and p27 (kip1) (1997) Mol. Endocrinol., 11, pp. 1593-1607
• Horwitz, K.B., Alexander, P.S., In situ photolinked nuclear progesterone receptors of human breast cancer cells: Subunit molecular weights after transformation and translocation (1983) Endocrinology, 113, pp. 2195-2201
• Ignar-Trowbridge, D.M., Teng, C.T., Ross, K.A., Parker, M.G., Korach, K.S., McLachlan, J.A., Peptide growth factors elicit estrogen-dependent transcriptional activation of an estrogen-responsive element (1993) Mol. Endocrinol., 7, pp. 992-998
• Ignar-Trowbridge, D.M., Nelson, K.G., Bidwell, M.C., Curtis, S.W., Washburn, T.F., McLachlan, J.A., Korach, K.S., Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 4658-4662
• Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Chambon, P., Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase (1995) Science, 270, pp. 1491-1494
• Kavanaugh, W.M., Williams, L.T., An alternative to SH2 domains for binding tyrosine phosphorylated proteins (1994) Science, 266, pp. 1862-1865
• Kiss, R., Paridaens, R.J., Heuson, J.C., Danguy, A.J., Effect of progesterone on cell proliferation on the MXT mouse hormone-sensitive mammary neoplasm (1986) J. Natl. Cancer Inst., 77, pp. 173-178
• Knotts, T.A., Orkiszewski, R.O., Cook, R.G., Edwards, D.P., Weigel, N.L., Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites (2001) J. Biol. Chem., 276, pp. 8475-8483
• Kraus, M.H., Issing, W., Miki, T., Popescu, N.C., Aaronson, S.A., Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 9193-9197
• Lanari, C., Kordon, E., Molinolo, A.A., Pasqualini, C.D., Charreau, E.H., Mammary adenocaminomas induced by medroxyprogesterone acetate: Hormone dependence and EGF receptors of BALB/c in vivo sublines (1989) Int. J. Cancer, 43, pp. 845-850
• Lange, C.A., Richer, J.K., Shen, T., Horwitz, K.B., Convergence of progesterone and epidermal growth factor signaling in breast cancer (1998) J. Biol. Chem., 273, pp. 31308-31316
• Lange, C.A., Shen, T., Horwitz, K.B., Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteosome (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 1032-1037
• Lewis, G.D., Lofgren, J.A., McMurtrey, A.E., Nuijens, A., Fendly, B.M., Bauer, K.D., Sliwkowski, M.X., Growth regulation of human breast and ovarian tumor cells by heregulin: Evidences for the requirement of ErbB-2 as a critical component in mediating heregulin responsivness (1996) Cancer Res., 56, pp. 1457-1465
• Lowenstein, E.J., Daly, R.J., Batzer, A.G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Schlessinger, J., The SH2 and SH3 domain-containing protein GrbB-2 links receptor tyrosine kinases to ras signaling (1992) Cell, 70, pp. 431-442
• Manni, A., Badger, B., Wright, C., Ahmed, J.R., Demers, L.M., Effects of progestins on growth of experimental breast cancer in culture: Interaction with estradiol and prolactin and involvement of the polyamine pathway (1987) Cancer Res., 47, pp. 3066-3071
• Marte, B.M., Graus-Porta, D., Jescke, M., Favor, D., Hynes, N.E., Taverna, D., NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells (1995) Oncogene, 10, pp. 167-175
• Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Auricchio, F., Activation of the Src/p21 ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (1998) EMBO J., 17, pp. 2008-2018
• Mockus, M.B., Horwitz, K.B., Progesterone receptors in human breast cancer: Stoichiometric translocation and nuclear receptor processing (1983) J. Biol. Chem., 258, pp. 4778-4783
• Molinolo, A.A., Lanari, C., Charreau, E.H., Sanjuan, N., Pasqualini, C.D., Mouse mammary tumors induced by medroxiprogesterone acetate: Immunochemistry and hormonal receptors (1987) J. Natl. Cancer. Inst., 79, pp. 1341-1350
• Montecchia, M.F., Lamb, C., Molinolo, A.A., Luthy, I.A., Pazos, P., Charreau, E.H., Vanzulli, S., Lanari, C., Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas (1999) J. Steroid Biochem. Mol. Biol., 68, pp. 11-21
• Mullik, A., Katzenellenbogen, B.S., Progesterone receptor synthesis and degradation in MCF-7 human breast cancer cells as studied by dense amino acid incorporation (1986) J. Biol. Chem., 261, pp. 13236-13243
• Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Pelicci, P.G., A novel transforming protein (SHC) and SH2 domain is implicated in mitogenic signal transduction (1992) Cell, 70, pp. 93-104
• Pietras, R.J., Arboleda, J., Reese, D.M., Wongvipat, N., Pegram, M.D., Ramos, L., Groman, C.M., Slamon, D.J., Her-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells (1995) Oncogene, 10, pp. 2435-2446
• Pinkas-Kramaski, R., Alroy, I., Yarden, Y., Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells (1997) J. Mamm. Gland Biol. Neoplasia, 2, pp. 97-107
• Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J., Shoyab, M., Molecular cloning and expression of an additional epidermal growth factor receptor-related gene (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 4905-4909
• Plowman, G.D., Culouscou, J.M., Whitney, G.S., Green, J.M., Carlton, G.W., Foy, L., Neubauer, M.G., Shoyab, M., Ligand-specific activation of HER4/p180erbB-4, a fourth member of the epidermal growth factor receptor family (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 1746-1750
• Poletti, A., Weigel, N.L., Identification of a hormone-dependent phosphorylation site adjacent to the DNA-binding domain of the chicken progesterone receptor (1993) Mol. Endocrinol., 7, pp. 241-246
• Power, R.F., Mani, S.K., Codina, J., Conneely, O.M., O'Malley, B.W., Dopaminergic and ligand-independent activation of steroid hormone receptors (1991) Science, 254, pp. 1636-1939
• Read, L.D., Snider, C.E., Miller, J.S., Green, G.L., Katzenellenbogen, B.S., Ligand-modulated region of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines (1988) Mol. Endocrinol., 2, pp. 263-271
• Richer, J.K., Lange, C.A., Manning, N.G., Owen, G., Powell, R., Horwitz, K.B., Convergence of progesterone with growth factor and cytokine signaling in breast cancer (1998) J. Biol. Chem., 273, pp. 31317-31326
• Riese D.J. II, Stern, D.F., Specificity within the EGF family/ErbB receptor family signaling network (1998) Bioessays, 20, pp. 41-48
• Saceda, M., Grunt, T., Colomer, R., Lippman, M., Lupu, R., Martin, M., Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines (1996) Endocrinology, 137, pp. 4322-4330
• Sartorius, C.A., Melville, M.Y., Hovland, A.R., Tung, L., Takimoto, G.S., Horwitz, K.B., A third transactivation function (AF3) of human progesterone receptors locate in the unique N-terminal segment of the B-isoform (1994) Mol. Endocrinol., 8, pp. 1347-1360
• Sarup, J.C., Rao, K.V.S., Fox, C.F., Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor (1988) Cancer Res., 48, pp. 50711-55078
• Sepp-Lorenzino, L., Eberhard, I., Ma, Z., Cho, C., Serve, H., Liu, F., Rosen, N., Lupu, R., Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells (1996) Oncogene, 12, pp. 1679-1687
• Shen, T., Horwitz, K.B., Lange, C.A., Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294 (2001) Mol. Cell. Biol., 21, pp. 6122-6131
• Shyamala, G., Schneider, W., Schott, W., Developmental regulation of murine mammary progesterone receptor gene expression (1990) Endocrinology, 126, pp. 2882-2889
• Takimoto, G.S., Hovland, A.R., Tasset, D.M., Melville, M.Y., Tung, L., Horwitz, K.B., Role of phosphorylation in DNA binding and transcriptional functions of human progesterone receptors (1996) J. Biol. Chem., 271, pp. 13308-13316
• Takimoto, G.S., Tasset, D.M., Eppert, A.C., Horwitz, K.B., Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: Analysis with zinc finger mutants and the progesterone antagonist ZK98299 (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 3050-3054
• Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J., Yarden, Y., A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor (1996) Mol. Cell. Biol., 16, pp. 5276-5287
• Ullrich, A., Coussens, L., Hayflick, J.S., Dull, T.J., Gray, A., Tam, A.W., Lee, J., Seeburh, P.H., Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells (1984) Nature, 309, pp. 418-425
• Wei, L.L., Krett, N.L., Francis, M.D., Gordon, D.F., Wood, W.M., O'Malley, B.W., Horwitz, K.B., Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonist and antagonists in breast cancer cells (1988) Mol. Endocrinol., 2, pp. 62-72
• Wei, L.L., Sheridan, P.L., Krett, N.L., Francis, M.D., Toft, D.O., Edwards, D.P., Horwitz, K.B., Immunologic analysis of human breast cancer progesterone receptors: Structure, phosphorylation, and processing (1987) Biochemistry, 26, pp. 6262-6272
• Weigel, N.L., Steroid hormone receptors and their regulation by phosphorylation (1996) Biochem. J., 319, pp. 657-667
• Yamamoto, T., Ikawa, S., Akiyama, T., An erbB-related gene, c-erbB-2, encodes a possible receptor protein similar to the epidermoid growth factor receptor (1986) Nature, 319, pp. 230-234
• Zhang, Y., Beck, C.A., Poletti, A., Edwards, D.P., Weigel, N.L., Identification of phosphorylation sites unique to the B form of human progesterone receptor (1994) J. Biol. Chem., 269, pp. 31034-31040
• Zhang, Y., Beck, C.A., Poletti, A., Edwards, D.P., Weigel, N.L., Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor (1995) Mol. Endocrinol., 9, pp. 1029-1040
• Zhang, Y., Beck, C.A., Poletti, A., Clement J.P. IV, Prendergast, P., Yip, T., Hutchens, T.W., Weigel, N.L., Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo (1997) Mol. Endocrinol., 11, pp. 823-832
• Zhang, Y., Bai, W., Allgood, V.E., Weigel, N.L., Multiple signaling pathways activate the chicken progesterone receptor (1994) Mol. Endocrinol., 8, pp. 577-584

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------